CARCINOSIN CORD

Manufacturer
Energique, Inc. | Apotheca Company
Effective date
2024-07-12
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:27:32

Label at a glance#

ProductCARCINOSIN CORD
Active ingredientHUMAN BREAST TUMOR CELL
Label structure9 sections

Dosage and administration

Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.

Label contents#

Full prescribing information#

ACTIVE INGREDIENT:

OTC - ACTIVE INGREDIENT SECTION

(in each drop): 24.98% of Carcinosin 30X, 60X, 100X, 200X; 0.10% of Carcinosin 12X.

INDICATIONS:

OTC - PURPOSE SECTION

May temporarily relieve symptoms of excessive weariness; symptoms ever changing and conflicting.**

**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

WARNINGS:

WARNINGS SECTION

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.

KEEP OUT OF REACH OF CHILDREN:

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

Adults and children 5 to 10 drops orally, 1 time daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional.

Consult a physician for use in children under 12 years of age.

INDICATIONS:

INDICATIONS & USAGE SECTION

May temporarily relieve symptoms of excessive weariness; symptoms ever changing and conflicting.**

**Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

INACTIVE INGREDIENTS:

INACTIVE INGREDIENT SECTION

Demineralized water, 20% Ethanol.

QUESTIONS:

OTC - QUESTIONS SECTION

Dist. by Energique, Inc.

201 Apple Blvd

Woodbine, IA 51579 800.869.8078

PACKAGE LABEL DISPLAY:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

ENERGIQUE
SINCE 1987
HOMEOPATHIC REMEDY

CARCINOSIN

CORD

2fl. oz. (60ml)

Carcinosin CordCarcinosin Cord

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
44911-0530-12024-07-12C16284748780-1d6a99b39-5237-a426-e053-dadaa90af4c2DRUG FACTS:
44911-0530-12022-01-28C16284748780-1d6a99b39-5237-a426-e053-dadaa90af4c2DRUG FACTS:

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
44911-0530-1CARCINOSIN CORD60 mL in 1 BOTTLE, DROPPERLIQUID602

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
44911-0530CARCINOSIN CORD (CARCINOSIN) LIQUID [ENERGIQUE, INC.]2Current NDC, Legacy NDC, 1 package rows20240713_e5a677f0-018d-4c93-ab2e-0ca1d7123d10.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
44911-053044911-0530-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Name, UNII, Kind table
NameUNIIKind
HUMAN BREAST TUMOR CELLC62OO7VD9KACTIB
WATER059QF0KO0RIACT
ALCOHOL3K9958V90MIACT

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CARCINOSIN CORDCARCINOSINEnergique, Inc.e5a677f0-018d-4c93-ab2e-0ca1d7123d102024-07-12WarningsExact identifier
ndc (package): 44911-0530-1
ndc (product): 44911-0530
ndc11 (package): 44911053001
spl id: 27185721-3e80-4d09-a3b7-ed3edfd44a4f
spl set id: e5a677f0-018d-4c93-ab2e-0ca1d7123d10

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.